EBIT: Income before interest and taxes.
Anika Therapeutics Inc. (ANIK) had EBIT of $-5.10M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$119.91M |
|
$-56.38M |
|
$43.91M |
|
$76.00M |
|
$125.01M |
|
$-5.10M |
|
$2.34M |
|
$-2.76M |
|
$-2.76M |
|
$-8.83M |
|
$-8.83M |
|
$-56.38M |
|
$-8.83M |
|
|
EBIT |
$-5.10M |
$3.02M |
|
14.72M |
|
14.72M |
|
$-3.83 |
|
$-3.83 |
|
| Balance Sheet Financials | |
$113.65M |
|
$38.99M |
|
$89.09M |
|
$202.74M |
|
$23.31M |
|
-- |
|
$25.45M |
|
$48.75M |
|
$153.99M |
|
$144.37M |
|
$153.99M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$5.40M |
|
$-8.33M |
|
$-12.73M |
|
$72.87M |
|
$57.16M |
|
$-15.71M |
|
$13.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
63.38% |
|
-4.25% |
|
-4.25% |
|
2.52% |
|
-2.31% |
|
-47.02% |
|
$-2.33M |
|
-- |
|
-- |
|
-- |
|
0.59 |
|
1.84 |
|
5.08 |
|
71.82 |
|
-5.73% |
|
-6.11% |
|
-4.35% |
|
-5.73% |
|
$10.68 |
|
$-0.16 |
|
$0.37 |
|